


Crispr Stem & Therapeutics
Biotechnology Research • Petah Tikva, Center District, Israel • 1-10 Employees
Company overview
| Headquarters | Petah Tikva, Center District, Israel |
| Website | |
| NAICS | 541714 |
| Keywords | Stem Cells, Startup, Patent, Cell Therapy, Crispr, Heart Attack, Chronic Heart Faluire, Ischemic Heart Disease, Myocardial Ischemia, Personalized Gene Therapy, Tissu Engineering |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at Crispr Stem & Therapeutics
Dalia El-Ani
Founder & CEO
About Crispr Stem & Therapeutics
CST Ltd. is an Israeli-based private company, established in 2018. Our vision Develop an innovative gene and cell therapy for acute myocardial ischemia following acute heart attack to save millions of patients. Mission Add a cardio-protective treatment to the standard of care. The aim of the current project is to prevent or to restrict cardiac scar tissue following acute heart attack and thus to reduce the incidence of heart failure (HF). Our vision is to offer a personalized cell therapy treatment, that will save lives and increase life expectancy following a heart attack.
Crispr Stem & Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Crispr Stem & Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Crispr Stem & Therapeutics has never raised funding before.
Crispr Stem & Therapeutics Tech Stack
Discover the technologies and tools that power Crispr Stem & Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Font scripts
WordPress themes
Web servers
JavaScript libraries
WordPress plugins
Programming languages
Blogs
JavaScript libraries
JavaScript libraries
Databases
Page builders
Miscellaneous
Frequently asked questions
4.8
40,000 users



